Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Molecular Profiling Institute

Molecular Profiling Institute?uq=3Oe4kK1Z
1996 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of laboratory and pathological testing services intended to translate genomic discoveries into enhanced patient care. The company develops several proprietary diagnostic tests to guide disease treatment based on individual patients genomic and proteomic profiling, as well as identifying molecular characteristics of tumors in cancer patients, helping the patient to get the right diagnosis and treatment at right time.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 445 North Fifth Street
  • 3rd Floor
  • Phoenix, AZ 85004
  • United States

Molecular Profiling Institute Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Molecular Profiling Institute‘s full profile, request access.

Request full access to PitchBook

Molecular Profiling Institute Executive Team (2)

Name Title Board
Seat
Contact
Info
Robert Penny Ph.D Chief Executive Officer & Chairman

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

Molecular Profiling Institute Board Members (2)

Name Representing Role Since Contact
Info
000000 00000000 Self Board Member 000 0000
000000 00000 00.0 Molecular Profiling Institute Chief Executive Officer & Chairman 000 0000